Your session is about to expire
← Back to Search
Screening, Brief Intervention, and Treatment
Identifying and prioritizing needs (5 minutes) for Substance Abuse
N/A
Waitlist Available
Led By Nicole Ennis, PHD
Research Sponsored by Florida State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
Study Summary
This trial is testing a method to help reduce substance misuse in older adults with HIV, which could have positive effects on public health and safety.
Eligible Conditions
- Substance Abuse
- HIV/AIDS
- Aging Adults
- Behavioral Intervention
- Infectious Diseases
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of Participants Ranking Intervention as Acceptable
Secondary outcome measures
Number of Participants Who Obtained Formal Substance Use Treatment
Number of Participants Who Used Different Types of Substances (Biologically Confirmed Via Urinalysis)
Number of Participants Who Used Different Types of Substances (Self-Reported)
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: SBIRT InterventionExperimental Treatment5 Interventions
The interventionist will discuss substance use and misuse, HIV, and the interaction of aging and substance use; will give the patient feedback on their NM-ASSIST score and assess the patient's readiness to change based on Prochaska's stages of change; motivational interviewing techniques to identify the patients' most salient reasons for addressing substance use issues. Identifying and prioritizing need; problem-solving techniques to help patients identify which services may best help them work towards their goals; will use a referral resource guide to provide the contact information of agency representatives and help the patient formulate a plan for follow-up.
Group II: Treatment as UsualActive Control1 Intervention
Participants in the enhanced care treatment as usual group will receive the same illustrated handout depicting their substance use screening score and the same referral resource guide provided to those in the control group. These will be provided with only a quick introduction by the research assistant to minimize intervention elements in the control condition and to resemble the notification and referral strategy that would be standard care.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Psycho-educational content (5 Minutes)
2018
N/A
~90
Readiness Assessment (10 minutes)
2018
N/A
~90
Goal-Setting (5 minutes)
2018
N/A
~90
Identifying and prioritizing needs (5 minutes)
2018
N/A
~90
Explanation of Peer Navigator and Session wrap (5 minutes)
2018
N/A
~90
Find a Location
Who is running the clinical trial?
National Center for Advancing Translational Sciences (NCATS)NIH
321 Previous Clinical Trials
401,663 Total Patients Enrolled
Florida State UniversityLead Sponsor
199 Previous Clinical Trials
31,605 Total Patients Enrolled
2 Trials studying Substance Abuse
222 Patients Enrolled for Substance Abuse
National Institute on Drug Abuse (NIDA)NIH
2,468 Previous Clinical Trials
2,619,263 Total Patients Enrolled
153 Trials studying Substance Abuse
707,142 Patients Enrolled for Substance Abuse
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger